Skip to main content
Back
DVA logo

DaVita Inc.

Data quality: 100%
DVA
NYSE Healthcare Medical - Care Facilities
$152.21
▲ $2.90 (1.94%)
Mkt Cap: 10.18B
Day Range
$150.71 $153.16
52-Week Range
$101.00 $159.42
Volume
532,394
50D / 200D Avg
$134.83 / $131.28
Prev Close
$149.31

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (626 peers)

Metric Stock Sector Median
P/E 13.6 0.4
P/B — 2.9
ROE % — 3.8
Net Margin % 5.5 3.9
Rev Growth 5Y % 4.1 10.0
D/E — 0.2

Analyst Price Target

Hold
$168.67 +10.8%
Low: $158.00 High: $190.00
Forward P/E
10.8
Forward EPS
$14.13
EPS Growth (est.)
+0.0%
Est. Revenue
14 B

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2029 $18.12
$17.77 – $18.76
 16 B 1
FY2028 $18.29
$17.93 – $18.94
 15 B 1
FY2027 $16.27
$16.21 – $16.34
 14 B 4

Key Takeaways

Revenue grew 4.10% annually over 5 years — modest growth
Earnings declined -20.24% over the past year
Generating 1.31B in free cash flow
P/E of 13.62 — trading at a low valuation
Cash machine — converts 175.50% of earnings into free cash flow
Capital efficient — spends only 4.22% of revenue on capex

Growth

Revenue Growth (5Y)
4.10%
Revenue (1Y)6.46%
Earnings (1Y)-20.24%
FCF Growth (3Y)-6.24%

Quality

Return on Equity
N/A
ROIC10.47%
Net Margin5.47%
Op. Margin14.74%

Safety

Debt / Equity
N/A
Current Ratio1.29
Interest Coverage3.66

Valuation

P/E Ratio
13.62
P/B RatioN/A
EV/EBITDA12.17
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 6.46% Revenue Growth (3Y) 6.01%
Earnings Growth (1Y) -20.24% Earnings Growth (3Y) 3.92%
Revenue Growth (5Y) 4.10% Earnings Growth (5Y) -6.53%
Profitability
Revenue (TTM) 13.64B Net Income (TTM) 746.80M
ROE N/A ROA 4.27%
Gross Margin 27.00% Operating Margin 14.74%
Net Margin 5.47% Free Cash Flow (TTM) 1.31B
ROIC 10.47% FCF Growth (3Y) -6.24%
Safety
Debt / Equity N/A Current Ratio 1.29
Interest Coverage 3.66 Dividend Yield 0.00%
Valuation
P/E Ratio 13.62 P/B Ratio N/A
P/S Ratio 0.75 PEG Ratio -1.11
EV/EBITDA 12.17 Dividend Yield 0.00%
Market Cap 10.18B Enterprise Value 24.47B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 13.64B 12.82B 12.14B 11.61B 11.62B
Net Income 746.80M 936.34M 691.54M 560.40M 978.45M
EPS (Diluted) 9.51 10.73 7.42 5.71 8.90
Gross Profit 3.68B 4.22B 3.82B 3.40B 3.65B
Operating Income 2.01B 2.09B 1.60B 1.34B 1.80B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 17.48B 17.29B 16.89B 16.93B 17.12B
Total Liabilities 16.32B 15.19B 14.15B 14.70B 14.75B
Shareholders' Equity -651.08M 121.12M 1.06B 712.33M 755.51M
Total Debt 15.05B 12.07B 11.12B 11.82B 11.98B
Cash & Equivalents 757.75M 794.93M 380.06M 244.09M 461.90M
Current Assets 4.06B 3.75B 3.14B 3.16B 3.17B
Current Liabilities 3.14B 2.97B 2.64B 2.62B 2.40B